Gastrointestinal bleeding as presentation of small bowel metastases of malignant melanoma: Is surgery a good choice?  by Conversano, Angelica et al.
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INTRODUCTION:  Melanoma  shows  a particular  predilection  in  involving  small  intestine  both  in a single
site and  in  multiple  localization  and  acute  or chronic  gastrointestinal  bleedings  are  often  the ﬁrst  sign  of
tumour.
PRESENTATION  OF  CASE:  We  report  two  cases  of  GI metastases  of  malignant  melanoma,  one  presented
with  only  a big  mass  that cause  intestinal  obstruction  and  the  other  with  a tumour  spread  throughouteywords:
elanoma metastasis
astrointestinal bleeding
mall intestine surgery
apsule endoscopy
the  small  intestine  that  produce  enterorrhagia.
DISCUSSION:  Diagnosis  and  follow-up  are  very  difﬁcult:  CT  scan,  PET-CT  scan  and  capsule  endoscopy
should  be  complementary  for  the  assessment  of patients  with  GI symptoms  and melanoma  history.
CONCLUSION:  What  is the role  of surgery?  Several  studies  suggest  metastasectomy  to  achieve  both  R0
results  and  palliative  resolutions  of  acute  symptoms,  such  as  obstruction,  pain,  and  bleeding.
© 2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Enterorrhagia is a common sign in patients who  come to a sur-
ical department; after the exclusion of benign diseases (such as
aemorrhoids, anal ﬁssures or IBD), we focus on gastro-intestinal
alignant tumours. However, even if colic or colorectal carcinomas
re very common, the incidence of tumours of the small intestine,
oth primary and secondary, is very low; this is even more true if
e consider the intestinal localization of melanoma, both in case
f metastatic and primary tumours.
What should we do in such clinical circumstances? We  report
wo cases of malignant melanoma metastasis; one was  presented
ith only a big mass and the other was with a tumour spreading
hroughout the small intestine. Diagnosis was not easy especially
ithout a previous clinical history of melanoma, or when it is omit-
ed at the hospitalization, as what happened in our second case.
evertheless some old and new devices could help surgeons, like
ET/CT scan and capsule endoscopy.14,16 Controversial is their use
n melanoma follow-up, considering their costs and the prolon-
ation of waiting lists. Despite that gastrointestinal investigations
such as faecal occult blood or colonoscopy) should be promoted
y clinicians for patients with melanoma in order to prevent bowel
etastasis complications.
∗ Corresponding author. Tel.: +39 080 5592345/339 7233478.
E-mail address: angelicaloco@hotmail.it (A. Conversano).
ttp://dx.doi.org/10.1016/j.ijscr.2014.09.003
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
In both our cases, surgery was performed with the aim to assure
the best local control of symptoms and guarantee better prognosis,
even in cases of spread involvement, according to several stud-
ies that support surgical treatment not only to obtain a complete
resection but also for palliative intent.18,21,23
2. Case 1
A 49-year-old man  with abdominal pain, anaemia and tarry
stools came to our attention in October 2009. He reported that the
symptoms started ten days before. Sixteen months before he under-
went a malignant melanoma excision from the right leg and two
months later a wide removal of skin around the ﬁrst excision with a
bilateral inguinal lymphadenectomy because of sentinel node pos-
itivity. Furthermore a secondary localization on the left cheekbone
was removed in September 2008 and the patient started traditional
chemotherapy with Dacarbazine in January 2009.
In order to determine the source of disease we arranged a CT
scan which showed an huge jejunal mass (8 cm of diameter) that
reduced intestinal lumen and determined dilatation of its upper
part. A bowel resection with L-L manual anastomosis was  per-
formed and the histological diagnosis was  “bowel localization of
melanocitic melanoma that involved 5 out of 7 mesenteric lymph
nodes”.
During the postoperative period the patient underwent PET/CT
scan which showed multiple brain recurrences. No postoperative
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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0Fig. 1. 18-FDG PET-CT scan re
hemotherapy was carried out and he died because of intracranial
leeding three months after abdominal surgery.
. Case 2
A 61-year-old man  was admitted to our Department on May
013 as emergency case because of gastrointestinal bleeding
nd anaemia. The patient’s medical history was  signiﬁcant for
ypertension, noninsulin-dependent diabetes mellitus and iron-
eﬁciency anaemia.
Anamnesis is also characterized by a diagnosis of skin melanoma
n the abdominal region on April 2011; however, the patient gave us
uch information only at the end of our surgical treatment. At that
ime a diagnostic excisional biopsy of the lesion was  performed and
he histological report conﬁrmed: “III Clark level, Breslow thickness
.55 mm malignant melanoma with the prevalence of superﬁcial the extension of the disease.
diffusion and without regression or vascular inﬁltration”. Conse-
quently a wide skin removal was  performed, because a melanoma
was found on the skin near to the previous excision. How-
ever the patient did not have sentinel lymph node biopsy
procedure or any follow-up control because he did not accept
them.
At the beginning of 2013 the patient had several episodes of
melena and, with the aim to discover the source of bleeding, we  per-
formed a colonoscopy with biopsy (the histological diagnosis was
hyperplasic adenomatosus polyp) and a gastroscopy which solely
showed an antral gastritis and an inﬂammatory stomach polyp.
Moreover the patient underwent abdominal US and MRI  and a total
body CT scan that showed right axillary lymphadenopaty, a nodular
lesion in the medial lobe of the right lung and a big mass (7 cm of
diameter) in the IV–VIII segment of the liver of which an US-guided
biopsy was  carried out. In addition we  founded an increase in the
tumour markers (TPA, NSE, S100B). For a more accurate diagnosis,
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4. DiscussionFig. 2. 18-FDG PET-CT
he patient underwent capsule endoscopy which showed a subtotal
tenosing vegetating ulcerating neoplasm of the upper jejunum
just below the Treitz’s ligament); because of this, it was impossible
o end the examination.
While we were waiting for the histological response of the
epatic biopsy, the patient had a severe enterorrhagia and he went
o ER, so we had to perform a laparotomy in order to remove the
ejunal neoplasm. Surprisingly, we found a catastrophic situation:
part from the jejunal localization, there were several small bleed-
ng nodes throughout the whole mucosal side of the small bowel,
ome of them appearing on the sierosal surface as black spots, and
ome mesenteric lymph nodes increased in volume and also black.
n order to reduce the risk of a rapid resumption of bleeding, we suc-
eeded in removing the duodenum-jejunal tract (30 cm of length
ith 15 nodes from 1 to 5 cm of diameter) and the majority of
he biggest nodes through both an ileal excision of a 17 cm seg-
ent which included 5 ulcerating neoplasm localizations from 0.5
o 2.5 cm of diameter and other three simple enucleations of lesions
ith a diameter of 2.5 cm.s hepatic metastasis.
The histological diagnosis about the bowel localizations was
“melanotic melanoma” and the one about the liver was “metastatic
localization of amelanotic melanoma”.
Afterwards the patient underwent 18-FDG PET-CT scan which
revealed the abnormal accumulation of radioactivity throughout
the bowel and gastric wall, at the VIII hepatic segment and at the
lymph nodes of the right axilla and the celiac tripod (Figs. 1 and 2).
In June 2013 the patient started traditional chemotherapy with
Fotemustine because he was B-RAF wild type and N-RAS negative
and he underwent the second cycle in July. During that period he
had recurrent episodes of enterorrhagia and he needed blood trans-
fusions. Unfortunately the disease did not stop its course and the
patient died because of heart failure in September 2013, four month
after diagnosis.Enterorrhagia is often the ﬁrst sign of a gastrointestinal tumour
and it is useful looking for bleeding localization. Intestinal lesions
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re mostly primary tumours, however in rare cases they may  be
etastases. Secondary localizations of solid tumour rarely involve
he small bowel; on the contrary melanoma shows an unusual
redilection to metastasize to the GI tract, especially the small
ntestine, for reasons that remain unclear1,2.
Only 1–5% cases of metastatic melanoma3 are diagnosed dur-
ng life because they are generally clinically asymptomatic in
he early stages. Diagnosis often takes place when an emergency
omplication occurs, such as intestinal perforation, obstruction,
ntussusception, and acute GI bleeding, as in our second case.4–9 In
ther circumstances, such as the ﬁrst patient, symptoms are non-
peciﬁc and a patient comes to our attention because of anaemia,
atigue, weight loss, abdominal pain, constipation, haematemesis,
iarrhoea with tarry stools, faecal blood test positive, and the pres-
nce of a palpable abdominal mass.
In a study conducted by Sanki et al.,10 the median interval
etween treatment of the ﬁrst melanoma and detection of GI
etastasis was 48 months (range 0–489), for Gutman et al.,11 38.5
onths (range 1–258). In our case reports this interval is 16 and 49
onths respectively.
Which is the best approach to investigate an acute or chronic
astrointestinal bleeding in patients with positive history of
elanoma? Unanimously the importance of routine investigations
or patients with recently diagnosed melanoma is emphasized in
rder to discover occult stage IV disease and improve survival
ut there is not a common approach on the management of such
atients. EGDS and colonoscopy are commonly used to identify
leedings from the upper or lower gastrointestinal tracts. We  won-
er if we have to perform them to all I–II stage melanoma patients.
Sometimes diagnosis could be obtained with computerized
omography (CT) even if its sensibility is only 68%.12 PET-CT scan
s more sensitive in detecting visceral and GI metastases than
ET alone or CT alone.13–15 However this imaging technique does
ot help to localize lesions accurately. Therefore Prakoso et al.16
uggest capsule endoscopy as a complementary assessment for
atients with GI symptoms and/or with melanoma history, even if
DG PET-CT scan results are negative.17 Nevertheless further ran-
omized studies should be managed with the aim to detect the
est sequence of diagnostic procedures and investigate if capsule
ndoscopy should be proposed even in emergency cases.
In our experience after sure diagnosis the best treatment of GI
etastases should be an aggressive approach both in emergency
ases and in the elective ones. According to several studies10,11,19–23
he ﬁrst aim should be the complete resection with no tumour
esidual (R0). Indeed it was seen that surgical removal of all vis-
ble abdominal tumour was associated with a median survival of
7 months11 and 1-year survival rate of 57%.10 Furthermore even
alliative surgery guarantees better prognosis with a median sur-
ival of 11 months compared with 5 for those treated by systemic
herapy and a 1-year survival rate of 34% instead of 41%.18
Thus surgery could improve local control of symptoms and give
 great expectance of life, even though it was carried out with
on-therapeutic intent. This was the goal in both of our cases. Nev-
rtheless when disease is widespread with various gastrointestinal
nd/or extra intestinal localizations then metastasectomy is seen
s a mere local therapy and a questionable solution of disseminate
isease.24,25 Once again we would underline the importance of pre-
perative assessment to achieve an accurate staging of melanoma
ith the aim to undergo surgery of only selected patients and to
emove all metastases or solve a bowel obstruction, stop bleed-
ng or relieve symptoms. According to ESMO guidelines adjuvant
ystemic therapy might be necessary. Unfortunately therapies for
etastatic disease are not standardized and they only provide a
alliative effect.
We  are waiting for results from a new multicenter phase III,
andomized trial that compares surgical resection versus medicalPEN  ACCESS
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therapy as initial treatment for patients with resectable stage IV
melanoma (NIH Clinical Trials Identiﬁer, NCT010013623).
5. Conclusion
Melanoma shows a particular predilection in involving small
intestine both in a single site and in multiple foci but diagnosis is
made during life only in 1–5% of patients. Since signs and symp-
toms are unspeciﬁc routinely bowel examination is unadvisable.
Nevertheless if enterorrhagia, anaemia or abdominal pain arise in
patients with an history of melanoma, then investigation should be
mandatory to understand if they could be possible manifestations
of metastatic spread. Blood examination, especially rising serum
S100 and LDH, PET-CT scan and capsule endoscopy may  lead to
an earlier diagnosis of systemic relapses. Surgery for patients with
stage IV melanoma should be the ﬁrst step of a combined ther-
apy. To date, the role of surgery for disseminate melanoma is to
obtain better survival incomes than systemic therapy even though
it is carried out for palliative intent. In order to prevent advanced
melanoma stage, we  should emphasize the importance of regular
follow-up.
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